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Abstract
Next-generation deep sequencing of small RNAs has unveiled the complexity of the microRNA (miRNA) transcriptome,
which is in large part due to the diversity of miRNA sequence variants (‘‘isomiRs’’). Changes to a miRNA’s seed sequence
(nucleotides 2–8), including shifted start positions, can redirect targeting to a dramatically different set of RNAs and alter
biological function. We performed deep sequencing of small RNA from mouse insulinoma (MIN6) cells (widely used as a
surrogate for the study of pancreatic beta cells) and developed a bioinformatic analysis pipeline to profile isomiR diversity.
Additionally, we applied the pipeline to recently published small RNA-seq data from primary human beta cells and whole
islets and compared the miRNA profiles with that of MIN6. We found that: (1) the miRNA expression profile in MIN6 cells is
highly correlated with those of primary human beta cells and whole islets; (2) miRNA loci can generate multiple highly
expressed isomiRs with different 59-start positions (59-isomiRs); (3) isomiRs with shifted start positions (59-shifted isomiRs)
are highly expressed, and can be as abundant as their unshifted counterparts (59-reference miRNAs). Finally, we identified 10
beta cell miRNA families as candidate regulatory hubs in a type 2 diabetes (T2D) gene network. The most significant
candidate hub was miR-29, which we demonstrated regulates the mRNA levels of several genes critical to beta cell function
and implicated in T2D. Three of the candidate miRNA hubs were novel 59-shifted isomiRs: miR-375+1, miR-375-1 and miR-
183-5p+1. We showed by in silico target prediction and in vitro transfection studies that both miR-375+1 and miR-375-1 are
likely to target an overlapping, but distinct suite of beta cell genes compared to canonical miR-375. In summary, this study
characterizes the isomiR profile in beta cells for the first time, and also highlights the potential functional relevance of 59-
shifted isomiRs to T2D.
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Introduction
miRNAs are short regulatory RNAs that are processed from
variable length primary transcripts through consecutive ribonu-
clease-mediated cleavage events [1,2]. miRNAs guide and tether
the RNA induced silencing complex (RISC) to specific RNAs in
order to regulate their stability and/or translation [3]. Numerous
studies have identified miRNAs as important modulators of a wide
variety of biological pathways [4,5]; for example, miR-375-
mediated gene regulation is critical for both beta cell development
and function [6,7].
Similar to protein coding genes, miRNAs are present in
multiple isoforms, called isomiRs [8–10]. IsomiRs are sequence
variants, generated from a single miRNA locus, that consist of one
or both of two types of variations: templated and non-templated
[9,11,12] (Fig. 1). Templated variants match the genomic
sequence, but have differing 59-start and/or 39-end positions,
likely due to processing heterogeneity by Drosha/Dicer [1,2] and/
or exonuclease-mediated nucleotide trimming [13,14]. Non-
templated isomiRs are diverged from the genomic sequence due
to post-transcriptional enzymatic processes that add, remove, or
edit specific nucleotides [10]. Nucleotide additions are catalyzed
by a class of enzymes called ribonucleotidyl transferases, which
modify miRNAs by covalent addition of nucleotides to the 39-end
[15]. The most prevalent form of RNA editing is the adenosine-to-
inosine edit, which is mediated by the double-stranded RNA
adenosine deaminase (ADAR) family of enzymes [16].
IsomiRs were initially dismissed as byproducts of technical (e.g.
sequencing errors) or biological noise [17,18]. However, recent
studies have shown that isomiRs interact with the RISC and are
present in polysomes [19–22], suggesting that they may be
biologically relevant. Several studies have demonstrated that 39-
non-templated nucleotide additions (39-NTAs), most commonly
uridylation or adenylation [19,22–27], affect miRNA stability
and/or loading onto the RISC [10,22,23] and are physiologically
regulated [15,28]. Also, several studies have identified isomiRs
generated by RNA edits at the 59-end of the miRNA [29–32],
referred to as the seed region, which is a critical determinant of
stable miRNA targeting [3]. Modifications to the seed region have
the potential to redirect a miRNA to a vastly different set of target
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RNAs, thereby potentially altering its biological function [29].
Perhaps the best-studied example of this phenomenon is the A-to-I
editing of the miR-376 primary transcript leading to the
expression of a 59-isomiR of miR-376 with a modified seed [29].
The canonical version of miR-376 and its seed-altered isomiR
were shown to have highly distinct target sets [29], highlighting the
biological importance of 59-isomiRs.
59-isomiRs are not limited to those generated by RNA edits;
they can also be produced by processing heterogeneity and/or 59-
end nucleotide trimming, which can shift the 59-start positions of
miRNAs (Fig. 1). 59-shifted isomiRs have been identified in a few
recent studies [19,22,24,33–35]; however, they are often reported
to be lowly expressed [19,24] and continue to be perceived as rare
[9]. As such, they are often overlooked by deep sequencing studies,
including those performed in pancreatic beta cells. Because the 59-
end of a miRNA is so critical for function, it is of substantial
interest to characterize comprehensively the prevalence and
physiological relevance of miRNA 59-diversity.
To that end, we developed an in-house bioinformatic analysis
pipeline for the quantitation of miRNAs and their 59-isomiRs in
mouse insulinoma cells (MIN6), which are widely used as a
surrogate for pancreatic beta cells [36]. Further, we applied the
pipeline to published small RNA-seq datasets from primary
human beta cells and whole islets. Strikingly, we found not only
that the miRNA expression profile in MIN6 cells correlates very
well with those of the primary human beta cells and islets
(r2.0.98), but also that 7 highly expressed 59-shifted isomiRs in
MIN6 cells are also abundant in human beta cells and whole islet.
Finally, using a Monte Carlo simulation strategy, we identified ten
beta cell miRNAs, including three 59-shifted isomiRs, as significant
candidate regulatory hubs in a T2D gene network.
Materials and Methods
Small RNA-seq Datasets
Small RNA-seq. MIN6 cells were cultured in high glucose
(25 mM) DMEM (Sigma) supplemented with 10% heat-inactivat-
ed fetal bovine serum. Cells were lysed and total RNA was
extracted using the Norgen total RNA purification kit. RNA
quality was assessed by Agilent 2100 Bioanalyzer, and only very
high quality samples with RNA Integrity Number (RIN) above 9.0
were considered further. Small RNA libraries (three biological
replicates) were generated using the Illumina TruSeq small RNA
library preparation kit. These libraries were then sequenced on the
Illumina HiSeq platform. Small RNA-seq data are available in the
GEO database (Accession ID: GSE44262). Sequencing of small
RNAs from mouse liver was conducted as well, in accordance with
the protocol described above.
Human primary cell data. Primary beta cell and whole islet
small RNA-seq datasets were obtained from GEO (GSE47720:
[37]). This study included two libraries of beta cells (GSM1155397
and GSM1155398) and one whole islet sample (GSM1155395)
that were prepared with the Illumina TruSeq protocol and
sequenced on the Illumina HiSeq platform.
Small RNA-seq Read Mapping Pipeline
Small RNA-seq reads are first trimmed by cutAdapt (param-
eters -O 10–e 0.1) to remove remnants of the 39-adaptor sequence
[38]. Next, trimmed reads of size 14–41 nt are mapped, without
Figure 1. Sources of isomiR diversity. The top panel illustrates sources of isomiR diversity, which stratify into two classes: templated and non-
templated variations. As illustrated by the bottom panel, an isomiR may contain one or both types of variations, and both templated (e.g. 59-shifts)
and non-templated (e.g. RNA edits) variations can create an isomiR with an altered seed. The seed region of each isomiR is underlined.
doi:10.1371/journal.pone.0073240.g001
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mismatches allowed, to the reference genome using Bowtie [39]
(parameter set: -q -a -m 20 -n 0 -e 70). All mapped reads separated
by 65 nt or less are merged. These merged windows are then
extended by 5 nt on either end. All remaining reads (those that
could not be mapped exactly by Bowtie) are aligned with
mismatches allowed to the extended windows using SHRiMP2
[40].
Specifically, the set of all possible ‘‘alignment seeds’’ containing
one mismatch in the body (M0) and up to three mismatches at the
39-end (depending on read length) is generated and used to align
all reads to the genomic windows. The number of mismatches
allowed at the 39-end (M1) for a read of length L is defined as:
M1 = 0 if L,16, M1 = 1 if 16#L,19, M1 = 2 if 19#L#23, and
M1 = 3 if L.23. Finally, all reads mapping equally well to multiple
loci are proportionally assigned to those loci. Mapped reads are
grouped by 59-start position (59-isomiRs) and are annotated with
respect to the start position of the reference miRNA (miRBase r18)
at the same locus [41]. For each miRNA or 59-isomiR, all reads
with mismatches at the 39-end are counted as 39-NTAs.
Mismatches within a read are counted as potential RNA edits.
For additional details see supplemental methods (File S1).
Candidate miRNA Regulatory Hub Identification in the
T2D Gene Network
T2D gene list. We identified the nearest genes to each
genetic variant significantly associated with T2D (p-values ,1027)
Figure 2. miRNA and isomiR profiles in MIN6 cells, primary human beta cells and human islet. (A) A heatmap is shown depicting the
Pearson correlation coefficients of miRNA profiles between pairs of samples analyzed in this study. (B) The x-axis depicts highly expressed miRNAs
ordered from left to right by decreasing maximal expression across all samples. The y-axis depicts the Log10 of the average read count per million.
Each dot represents a miRNA. miRNAs from a homogenous locus (a pre-miRNA that produces only one mature miRNA per arm of the hairpin) are in
gray. miRNAs from a heterogeneous locus (a pre-miRNA that produces more than one mature miRNA per arm of the hairpin) are either pink (59-
reference) or blue (59-shifted).
doi:10.1371/journal.pone.0073240.g002
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from (1) the T2D genome-wide association studies (GWAS) listed
in the NHGRI catalog (http://www.genome.gov/gwastudies) and
(2) a T2D GWAS reported by Morris et al. that was not included
in the NHGRI catalog [42]. Additionally, we included twenty-
three genes linked to maturity onset diabetes of the young
(MODY), neonatal diabetes (NDM), and chronic hyperinsulin-
emia (CHI). The total number of genes was 92.
Identification of miRNA regulatory hubs. Candidate
miRNA regulatory hubs in the T2D gene network were identified
by Monte Carlo simulation analysis. First, we used the seed-based
target prediction algorithm TargetScanS 5.2 [43] to determine for
each beta cell miRNA the number of predicted conserved targets
among the human genes in the T2D network. Each predicted
miRNA – gene interaction was assigned a score based on the
strength of the seed match, the level of conservation of the target
site, and the clustering of target sites within that gene’s 39-UTR.
Additionally, the score for each gene was weighted according to
the number of high-confidence protein-protein interactions
Figure 3. Comparison of 59-reference miRNA and 59-shifted isomiR expression levels among MIN6 cells, human beta cells, and
human islet. (A) The x-axis lists selected 59-reference miRNAs in MIN6 (red), human beta cells (green), and human islets (blue). The y-axis depicts the
Log10 of the average read count per million for each 59-reference miRNA in each sample. (B) The x-axis shows the highly expressed 59-shifted isomiRs
ordered from left to right by decreasing fold-difference between primary human beta cells and MIN6 cells. The y-axis depicts the average read count
per million for each 59-shifted isomiR. (C) The number of genes with at least one conserved target site for miR-375 (gray), miR-375+1 (green), and miR-
375-1 (orange) is shown. All sets are mutually exclusive: for example, a total of 390 genes have predicted conserved miR-375 target sites (42 unique to
miR-375, 3 shared with miR-375+1 only, 337 shared with miR-375-1 only, and 8 common to all three).
doi:10.1371/journal.pone.0073240.g003
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reported in the STRING 9.0 database [44]. Finally, for each
miRNA, the final targeting score was calculated by summing the
scores across all genes and dividing by the number of genes. We
repeated this procedure 30,000 times, with a new set of randomly
selected human genes each time, in order to generate a
background distribution of the predicted targeting scores for each
miRNA (genes and corresponding 39-UTR sequences were
downloaded from http://www.targetscan.org). These score distri-
butions were then used to calculate an empirical p-value of the
targeting score for each miRNA in the T2D gene set. Genes were
selected at random from a pool with similar overall connectivity to
the genes in the T2D gene set, and to account for differences in the
average 39 UTR length between the genes of interest and the
randomly selected genes in each simulation, the targeting score
was normalized by 39 UTR length. For additional details see
supplemental methods (File S1).
Validation of miRNA-mediated Gene Regulation
MIN6 cells were transiently transfected with (1) 10 nM mmu-
miR-29 mimic (Dharmacon); (2) 200 nM mmu-miR-29 hairpin-
inhibitor (Dharmacon); (3) 10 nM mmu-miR-375 mimic (Dhar-
macon); (4) 10 nM custom mmu-miR-375+1 mimic (Dharmacon:
59-UUGUUCGUUCGGCUCGCGUGA-39) or (5) 10 nM cus-
tom mmu-miR-375-1 mimic (Dharmacon: 59UUUUGUUC-
GUUCGGCUCGCGUGA-39). After 48 hours, RNA was ex-
tracted from cells using the Norgen Total RNA Purification Kit,
and miRNA and mRNA levels were measured by real-time
quantitative PCR (RT-qPCR) using TaqMan microRNA and
gene assays (Applied Biosystems).
Results
Comparing the miRNA and 59-isomiR Profiles of MIN6,
Human Beta Cell, and Human Islet
To characterize isomiR diversity (Fig. 1) in mouse insulinoma
cells (MIN6), we generated small RNA libraries (n = 3) and
performed deep sequencing on the Illumina HiSeq platform
(Methods), which yielded ,18 million reads per replicate. After 39-
adaptor trimming, on average ,50% of the reads were within the
expected size range (16–27 nt) for miRNAs (Table S1 in File S2).
Figure 4. Candidate miRNA regulatory hubs in a type 2 diabetes gene network. (A) Each data point represents a 59-reference miRNA or a
59-shifted isomiR from primary human beta cells, and the y-axis shows the negative Log2 of the p-value of the predicted miRNA targeting score
among genes in a type 2 diabetes (T2D) network. The dashed red line denotes the significance threshold (empirical P = 0.05). (B) Effects of miR-29
mimic and inhibitor in MIN6 cells on the mRNA levels of four T2D genes are shown. The x-axis lists the gene symbols for each of four predicted miR-
29 target genes and the y-axis depicts the relative quantitative value (RQV; expression determined by RT-qPCR and normalized to Rps9) in response to
the miR-29 mimic (blue) or the miR-29 inhibitor (red) relative to mock transfection. The data shown represent at least two independent experiments,
each conducted in triplicate. P-values were calculated based on Student’s t-tests. *, P,0.05; **, P,0.01.
doi:10.1371/journal.pone.0073240.g004
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To analyze the small RNA-seq reads further, we developed and
implemented an in-house bioinformatic analysis pipeline for highly
sensitive detection and quantitation of isomiRs (Methods, Fig. S1
in File S1). We successfully mapped ,92% of the trimmed MIN6
reads in each replicate and on average ,75% of the mapped reads
corresponded to annotated miRNA loci (Table S1 in File S2).
We also used our pipeline to analyze published small RNA-seq
datasets from primary human beta cells (n = 2) and whole islet
(n = 1) [37]. These datasets had approximately 41, 33 and 79
million reads respectively, and in each case more than 80% of the
39-adaptor trimmed reads were within the expected size range
(16–27 nt) for miRNAs (Table S1 in File S2). We successfully
mapped ,97% of the trimmed reads and on average ,85% of the
mapped reads corresponded to annotated miRNA loci (Table S1
in File S2).
In each of the datasets, .1,000 distinct mature miRNAs were
represented by at least ten reads. However, 98% of the miRNA-
related reads captured the top ,100–150 mature miRNAs
depending on the dataset. We refer to these miRNAs as ‘‘highly
expressed.’’ To compare miRNA profiles across the MIN6
replicates and human samples, we first assembled a list of miRNAs
that were ‘‘highly expressed’’ in at least one dataset, resulting in
209 distinct mature miRNAs produced from 187 unique pre-
miRNAs (Table S2 in File S2). These 187 pre-miRNAs consisted
of:
(1) 166 pre-miRNAs that generate at most one mature miRNA
from each arm of the hairpin-like structure (‘‘homogenous
loci’’), including one locus (pre-miR-5099) that produces only
a 59-shifted isomiR (mmu-miR-5099-2); and
(2) 21 pre-miRNAs that generate more than one mature miRNA
from the same arm (‘‘heterogeneous loci’’), including one
locus (pre-miR-375) that produces one 59-reference miRNA
and two 59-shifted isomiRs.
Among the 209 mature miRNAs, 186 were 59-reference
miRNAs and 23 were 59-shifted isomiRs (Table S2 in File S2).
The miRNA profiles of each of the MIN6 replicates correlated
extremely well with each other (r2,0.99) and, strikingly, also with
those of the human beta cells (average r2 = 0.98) and whole islets
(average r2 = 0.97) (Fig. 2A; Table S2 in File S2). As a control, we
also sequenced libraries of small RNAs from the mouse liver
prepared according to the same protocol and determined that as
expected the correlation with the MIN6 profile was very poor
(r2,0.1; data not shown). The isomiRs from the heterogeneous
loci were distributed across the spectrum of highly expressed
miRNAs (Fig. 2B), indicating that the heterogeneous status of a
miRNA locus is not merely a function of the level of expression.
Although miRNA expression among these samples was highly
correlated overall, such as in the case of miR-22-3p or miR-24-1-3p
(Fig.3A), severalmiRNAsappearedtobespecificallyorpreferentially
expressed ineither theMIN6cellsorhumanbetacells/islets (Fig.3A).
For example, miR-143-3p and miR-204-5p were 791- and 265-fold
more highly expressed, respectively, in the human beta cells than in
the MIN6 cell line (Fig. 3A). Likewise, miR-93-5p and miR-409-5p
were 38- and 85-fold more highly expressed, respectively, in MIN6
cells than in human beta cells (Fig. 3A).
Characterization of Beta Cell 59-shifted isomiRs
Of the 23 highly expressed MIN6 59-shifted isomiRs, only
mmu-miR-5099-2 and mmu-miR-101b-3p-1 did not have a
homologous miRNA in the human samples. Among the remaining
21, two were in the set of top 20 most highly expressed miRNAs in
each of the MIN6 and human datasets: miR-375+1 and miR-375-
1. Many of the 59-shifted isomiRs, such as miR-375+1, miR-375-1,
and miR-27b-3p-1, were expressed at similar levels in MIN6,
human beta cell, and human islet samples (Fig. 3B). However,
some 59-shifted isomiRs were preferentially associated with either
MIN6 or one of the human samples. For example, miR-192-5p+1
was 22-fold more highly expressed in human beta cells than in
MIN6, miR-10a-5p+1 was 23-fold more highly expressed in
human islets than in MIN6, and miR-183-5p+1 was nearly 3-fold
more highly expressed in MIN6 than in human beta cells or islets
(Fig. 3B). These differences are likely in part a reflection of the
disparities in cellular composition among MIN6 cells, beta cells,
Figure 5. Evaluation of miR-375 and its 59-shifted isomiRs in MIN6 cells. Effects of mimics for 59-reference miR-375, 59-shifted miR-375+1,
and 59shifted miR-375-1 in MIN6 cells on the mRNA levels of three genes are shown. Mtpn is a known target of 59-reference miR-375 but not
predicted as a target for either of the 59-shifted miR-375 isomiRs; Atp6v0c is predicted to be preferentially targeted by miR-375+1; and Cdc42 is
predicted to be preferentially targeted by miR-375-1. The x-axis lists the gene symbols for each of three genes tested. The y-axis depicts the relative
quantitative value (RQV; expression determined by RT-qPCR and normalized to Rps9) in response to the miR-375 mimic (gray), miR-375+1 mimic
(orange), or miR-375-1 mimic (green) relative to mock transfection. The data shown represent at least two independent experiments, each conducted
in triplicate. P-values were calculated based on Student’s t-tests. *, P,0.05; **, P,0.01, ***, P,0.001.
doi:10.1371/journal.pone.0073240.g005
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and whole islets. Nevertheless, the overall profile of 59-shifted
isomiRs was fairly highly correlated between MIN6 and human
beta cells/islets (r2,0.7).
To illustrate the potential regulatory impact of these 59-shifted
isomiRs we used TargetScan [43] to predict targets for miR-375
and its 59-shifted isomiRs, miR-375+1 and miR-375-1. While
miR-375 has 390 predicted targets conserved between human and
mouse, miR-375-1 targets has more than twice that many, and
strikingly, miR-375+1 has only 14 (Fig. 3C). Only eight genes
(ELAVL4, HNF1B, NFIX, NPAS3, PAX2, SHOX2, SLC16A2, and
TSC22D2) have predicted conserved target sites for miR-375 and
both of its 59-shifted isomiRs.
Candidate 59-shifted isomiR Regulatory Hubs in Type 2
Diabetes
Genome-wide association studies for type 2 diabetes (T2D) have
primarily (though not exclusively) implicated genes with critical
function in the pancreatic beta cell [45,46]. Therefore, we sought
to determine if any of the highly expressed human beta cell
miRNAs, including 59-shifted isomiRs, serve as regulatory hubs in
T2D. We first assembled a list of genes (n = 92) implicated in T2D
and related conditions including maturing onset diabetes of the
young (MODY) (Methods). We then implemented a Monte Carlo
simulation strategy (Methods) to determine for each miRNA
whether the predicted regulatory impact on T2D genes is
significantly (uncorrected P,0.05) greater than expected by
chance (such miRNAs are termed ‘‘candidate regulatory hubs’’).
We identified 10 candidate miRNA regulatory hubs (Fig. 4A;
Table S3 in File S2). The top two were the 59-reference miRNAs
miR-29 and let-7, both of which have been implicated in beta cell
function and glucose homeostasis [47–49]. Though miR-29 has
been shown to regulate glucose-stimulated insulin secretion, its
target genes in the beta cell are largely unknown. To validate the in
silico approach, we selected several predicted targets (Camk1d, Glis3,
and Jazf1), and one previously validated target (Slc16a1 [48]), of
miR-29 from among the T2D gene list for evaluation in MIN6
cells. Specifically, we transiently transfected MIN6 cells with a
miR-29 mimic or inhibitor (antagomiR) and measured the mRNA
levels of each of the four genes by real-time quantitative PCR (RT-
qPCR). Three of the four genes were significantly (p,0.05) down
regulated by the over-expression of miR-29 and three genes were
significantly (p,0.05) up regulated by the antagomiR-mediated
inhibition of miR-29 (Fig. 4B). These findings are consistent with
previous reports that miR-29 is involved in the regulation of beta
cell function [48,50], and they serve as a validation of the in silico
regulatory hub analysis.
Strikingly, three of the 10 candidate miRNA regulatory hubs in
the T2D gene network were 59-shifted isomiRs: miR-375+1, miR-
375-1, and miR-183-5p+1 (Fig. 4A). Moreover, all three of these
were more significantly associated with T2D genes than their 59-
reference counterparts (Table S3 in File S2). This is particularly
intriguing, given the already well-established role of 59-reference
miR-375 in beta cell formation and function.
59-shifted isomiRs of the Beta Cell-enriched miRNA, miR-
375
As depicted in Fig. 3C, miR-375 and its 59-isomiRs have
overlapping, but distinct predicted target gene profiles. To further
evaluate the putative differential targeting of the miR-375 59-
isomiRs, we selected the following three genes: Mtpn, which
regulates insulin secretion, is a known target of the 59-reference
miR-375 [6], but is not predicted to be targeted by the 59-shifted
isoforms; Atp6v0c, which mediates glucose-sensitive intracellular
vesicular transport and is predicted to be preferentially targeted by
the 59-shifted isoform miR-375+1; and Cdc42, which is essential for
the second phase of insulin secretion and is predicted to be
preferentially targeted by the 59-shifted isoform miR-375-1. We
transfected MIN6 cells with (1) transfection reagent only (mock),
(2) 10 nM of miR-375 mimic, or (3) 10 nM of a mimic for one of
the 59-shifted isomiRs of miR-375, and measured the mRNA
levels of each of the three genes by RT-qPCR. Mtpn was repressed
only by the 59-reference miRNA (Fig. 5). Atp6v0c and Cdc42 were
also modestly repressed by the 59-reference miRNA, though
slightly more so by miR-375+1 and miR-375-1, respectively
(Fig. 5). In each case, the strongest repression was conferred by the
59-isomiR with the strongest predicted target site.
Discussion
In this study we developed an in-house bioinformatic analysis
pipeline to characterize isomiR diversity, and applied this method
to study isomiR expression in the MIN6 cell line, primary human
beta cells and islets. We found that (1) the miRNA expression
profile in the MIN6 cell line is highly correlated with that of the
primary human beta cells, (2) miRNA loci can be classified as
either homogeneous (producing a single highly expressed 59-
isomiR) or heterogeneous (producing multiple highly expressed 59-
isomiRs), (3) 59-shifted isomiRs can be as abundant as their 59-
reference counterparts, and (4) there are seven 59-shifted isomiRs
highly expressed in MIN6 cells that are also abundant in human
beta cells and islets. Additionally, we identified 10 beta cell
miRNAs, including three 59-shifted isomiRs, as candidate
regulatory hubs in type 2 diabetes. We evaluated several predicted
gene targets of our top candidate regulatory hub, miR-29, and
demonstrated the potential of the 59-shifted isomiRs miR-375+1
and miR-375-1 to differentially regulate gene expression in MIN6
cells.
While the unambiguous validation of the targeting activity of 59-
shifted isomiRs is important, it is hindered by inherent limitations
of the currently available technologies. For example, the gold
standard experiment would be to specifically knock-down the 59-
shifted isomiR of interest. However, current strategies for knock-
down (e.g. locked nucleic acids), and for testing the efficacy of the
knock-down (e.g. TaqMan RT-qPCR), do not adequately
distinguish between the 59-reference and 59-shifted isoforms.
New approaches for studying miRNA function must be developed
in order to tackle the technical challenges posed by 59-shifted
isomiRs, which are often identical in sequence to the 59-reference
form except for the addition/loss of a single nucleotide at the 59-
end. Though outside the scope of this study, further analyses are
necessary to firmly establish the functional relevance of the 59-
shifted isomiRs. Nonetheless, to our knowledge, this is the first
report of highly expressed 59-shifted isomiRs in beta cells, several
of which are candidate regulatory hubs in T2D.
The findings in this study promote the notion that 59-shifted
isomiRs are prevalent and potentially impact disease, thus
widening the panoramic view of the functional miRNA-ome. In
addition, we have identified for the first time three 59-shifted
isomiRs as significant candidate regulatory hubs in a disease
network. The novel strategy employed in this study can be utilized
for additional disease models to uncover potential roles for 59-
shifted isomiRs in the regulatory networks of complex diseases.
Supporting Information
File S1 Supporting methods and figures. Figure S1.
Overview of tiered mapping strategy. Trimmed reads are
mapped in a tiered fashion to the genome. First, reads that map
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exactly to transcriptionally active regions (as determined by
nascent RNA-seq) of the genome are used to create genomic
windows. Next, any remaining un-mapped reads are allowed to
map imperfectly only to the genomic windows generated in step 1,
as opposed to the entire genome, thereby drastically reducing the
mapable space. All reads that map equally well to multiple loci are
proportionally assigned to all those loci.
(DOCX)
File S2 Supporting tables. Table S1: Table listing statistics
for each of the small RNA-seq datasets used in this study.
Biological replicates for MIN6 are annotated as MIN-1, MIN6-2,
and MIN6-3. Table S2: This table lists the top miRNAs that
constitute 98% of all reads mapping to miRNA loci (‘‘highly
expressed’’). Each entry lists the mouse miRNA name and the
corresponding human miRNA name (based on miRBase r18); if
the miRNA is not found (meaning not present in miRBase r18) in
either species it is noted with the prefix NF and the entry is
highlighted in red. 59-shifted isomiRs are highlighted in green.
Each entry of the table lists the relative expression, expression
rank, and % NTAs for each sample. MIN6 replicates are denoted
by increasing sample number; primary human beta cell and whole
islets are labeled by their SRA number. The relative expression of
each miRNA is computed as the number of reads mapping to that
miRNA over the total number of mapped reads multiplied by one
million. As such, this number reports the expected relative
expression per million mapped reads. The rank column reports
the miRNA’s expression rank in each sample (a blank in the rank
column indicates that that miRNA was not deemed to be ‘‘highly
expressed’’ in that sample). The %NTA column indicates the
percent of reads mapping to a particular miRNA reported to have
a 39-non-templted nucleotide addition. Additionally the average
and standard deviation of expression for the MIN6 samples are
provided in the dark blue column, and an average is provided for
the 2 human beta cell libraries. Table S3: This table lists the
predicted targets among T2D genes (n = 92) for miRNA families
highly expressed in primary human beta cells. All target sites are
required to be conserved among humans and two other species
among mouse, rat, dog and chicken. Targeting score is calculated
as detailed in the supplemental methods and miRNA families are
sorted by empirical p-value.
(XLSX)
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